Two IBS patients with diagnostic and treatment challenges

Gastroenterology and Hepatology

Volumn 5, Issue 1 SUPPL. 1, 2009, Pages 4-6

  Burbige, Eugene J ^a  

^a John Muir Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; CHOLINERGIC RECEPTOR BLOCKING AGENT; LAXATIVE; LUBIPROSTONE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; DIARRHEA; DRUG WITHDRAWAL; FEMALE; HUMAN; IRRITABLE COLON; LABORATORY TEST; LIFESTYLE MODIFICATION; MALE; PHYSICAL EXAMINATION; SIGMOIDOSCOPY; XEROSTOMIA;

EID: 61449115799     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Brandt LJ, Locke R, Olden K, et al. An evidence based approach to the diagnosis of irritable bowel syndrome in North America. Am J Gastroenterol. 2002;97(Suppl 11): S1-S26.
2. Halvorson HA, Schett CD, Riddle MS. Post-infectious irritable bowel syndrome. Am J Gastroenterol. 2006;101:1894-1899.
3. Spiller RC. Role of infection in irritable bowel syndrome. J Gastroenterol. 2007;42(suppl 17):4l-47.
4. Marshall JK, Thabane M, Garg AX, et al. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology. 2006; 131:445-450.
5. Whitehead WE, Crowell MD, Robinson JC, et al. Effects of stressful life events on bowel symptoms-subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut. 1992;33:825-830.
6. Hazlett-Stevens H, Craske MG, Mayer EA, et al. Prevalence of irritable bowel syndrome among university students: the roles of worry, neurotocism, anxiety, sensitivity, and visceral anxiety. J Psychosomatic Res. 2003;55:501-505.
7. Poynard T, Regimbeau C, Benhamou Y. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2001;15:355-361.
8. Krause R, Ameen V, Gordon SH, et al. A randomized, double-blind, placebo- controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS. Am J Gastroenterol. 2007;102:1-11.
9. Johanson JF, Morton D, Greenen J, et al. Mulricenter, 4 week, double-blind, randomized trial of bprostone, a locally-acting type-2 chloride channel acrivator, in patients with constipation. Am J Gastroenterol. 2008; 103:170-177.